ACRS 8-K: SEC filing
Aclaris Therapeutics
Filed with the SEC on · accession 0001104659-26-123039
ACRS filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -1.9% by the first close after the filing.
Summary of the filing
Aclaris Therapeutics issued a press release announcing its financial results for the quarter and nine months ended September 30, 2026, furnished as Exhibit 99.1 to this Form 8-K.
Key details
How ACRS stock reacted
Close before
$3.68
Nov 4, 2026
First close after
-1.90%
$3.61
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ACRS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ACRS?
Click hereFrequently asked questions
What did ACRS file with the SEC on Nov 5, 2026?
ACRS filed a 8-K (SEC filing). Aclaris Therapeutics issued a press release announcing its financial results for the quarter and nine months ended September 30, 2026, furnished as Exhibit 99.1 to this Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did ACRS stock react to this filing?
ACRS closed at $3.68 before the filing and $3.61 on Nov 5, 2026 (-1.90%).
Other ACRS SEC filings
Get alerts when ACRS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days